Techno Medica Co., Ltd. (TYO:6678)

Market Cap	14.71B +21.5%
Revenue (ttm)	11.24B +13.4%
Net Income	1.07B +6.6%
EPS	155.14 +7.0%
Shares Out	6.97M
PE Ratio	13.61
Forward PE	n/a
Dividend	68.00 (3.29%)
Ex-Dividend Date	Mar 30, 2026

Volume	10,400
Average Volume	15,780
Open	2,099.00
Previous Close	2,066.00
Day's Range	2,097.00 - 2,131.00
52-Week Range	1,783.00 - 2,787.00
Beta	0.25
RSI	42.31
Earnings Date	May 11, 2026

About Techno Medica

Techno Medica Co., Ltd. engages in the research and development, manufacture, sale, import, and export of in-vitro diagnostic analyzers in Japan. The company offers automated tube selecting and labeling systems, RFID process control system, blood and urine collection support, and pre-analytical instrument. It also provides consumables and after sales services. Techno Medica Co., Ltd. was incorporated in 1987 and is headquartered in Yokohama, Japan.

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1987
• Employees: 244
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 6678

Financial Performance

In fiscal year 2026, Techno Medica's revenue was 11.24 billion, an increase of 13.44% compared to the previous year's 9.91 billion. Earnings were 1.07 billion, an increase of 6.57%.